Harvey Bryce M 4
4 · HI TECH PHARMACAL CO INC · Filed Jul 23, 2010
Insider Transaction Report
Form 4
Harvey Bryce M
Officer
Transactions
- Sale
Common Stock
2010-07-16$20.49/sh−2,800$57,383→ 950 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-07-16+1,250→ 3,750 totalExercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2010-07-16$5.83/sh+1,250$7,288→ 3,750 total - Exercise/Conversion
Common Stock
2010-07-16$9.93/sh+2,500$24,825→ 2,500 total - Sale
Common Stock
2010-07-16$20.49/sh−950$19,466→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-07-16−2,500→ 2,500 totalExercise: $9.93From: 2008-12-28Exp: 2017-12-28→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Stock Options were granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- [F2]The option becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F3]Other than the option to acquire 2,500 and 3,750 shares reflected on this form as still held by Mr. Harvey , Mr. Harvey is also the holder of an additional option to acquire 5,000 shares of Hi-Tech Common Stock, (for aggregate options to acquire a total of 11,250 shares currently held by Mr. Harvey), which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.